Teva Pharmaceutical Industries Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Teva Pharmaceutical Industries Limited's balance sheet done over the years? Its assets were worth $43,479,000,000 last year, which is less than in the previous period. 81% of Teva Pharmaceutical Industries Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $35,353,000,000, which means an increase by 0% compared compared to last year.
Debt to Assets
| 2014 | 46420000000 | 23.06B | 49.69% |
|---|---|---|---|
| 2015 | 54258000000 | 24.33B | 44.84% |
| 2016 | 92890000000 | 57.89B | 62.33% |
| 2017 | 70615000000 | 51.87B | 73.45% |
| 2018 | 60683000000 | 44.88B | 73.97% |
| 2019 | 57470000000 | 42.40B | 73.79% |
| 2020 | 50640000000 | 39.57B | 78.16% |
| 2021 | 47666000000 | 36.42B | 76.41% |
| 2022 | 44006000000 | 35.31B | 80.25% |
| 2023 | 43479000000 | 35.35B | 81.31% |
TEVJF Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 3.22B | 2.80B | 2.16B | 2.17B | 1.97B | 1.78B | 963M | 988M | 6.94B | 2.22B |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 14M | 10M | 11M | 73M |
Net receivables | 3.40B | 3.69B | 4.52B | 4.58B | 5.67B | 5.82B | 7.12B | 7.52B | 5.35B | 5.40B |
Inventory | 4.02B | 3.83B | 3.81B | 4.40B | 4.42B | 4.73B | 4.92B | 4.95B | 3.96B | 4.37B |
Other current assets | 1.83B | 549M | 967M | 710M | 434M | 468M | 2.35B | 1.29B | 2.09B | 2.31B |
Total current assets | 12.48B | 12.05B | 12.57B | 13.00B | 13.46B | 13.79B | 15.38B | 16.96B | 18.39B | 14.39B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.14B | 6.15B | 6.47B | 6.85B | 6.95B | 6.86B | 7.67B | 8.07B | 6.54B | 6.53B |
Goodwill | 17.17B | 17.63B | 20.04B | 20.62B | 24.84B | 24.91B | 28.41B | 44.40B | 19.02B | 18.40B |
Intangible assets | 5.38B | 6.27B | 7.46B | 8.92B | 11.23B | 14.00B | 17.64B | 21.48B | 7.67B | 5.51B |
Long term investments | 8M | 0 | 0 | 0 | 0 | 58M | 83M | 88M | 1.44B | 176M |
Other non-current assets | 2.27B | 441M | 515M | 538M | 591M | 673M | 849M | 1.14B | 2.61B | 1.56B |
Total non-current assets | 30.99B | 31.95B | 35.09B | 37.63B | 44.00B | 46.88B | 55.23B | 75.92B | 35.86B | 32.02B |
Total assets | 43.47B | 44.00B | 47.66B | 50.64B | 57.47B | 60.68B | 70.61B | 92.89B | 54.25B | 46.42B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 1.45B | 7.01B | 7.28B | 8.72B | 9.44B | 11.44B | 725M | -1.91B | -3.17B |
Short term debt | 1.67B | 2.10B | 1.42B | 3.18B | 2.34B | 2.21B | 3.64B | 3.27B | 1.59B | 1.76B |
Total current liabilities | 12.24B | 11.46B | 11.02B | 13.16B | 13.67B | 14.32B | 17.92B | 18.51B | 13.00B | 12.28B |
| Non-current liabilities: | ||||||||||
Long term debt | 18.48B | 19.45B | 22.03B | 23.21B | 24.99B | 26.7B | 28.82B | 32.52B | 8.38B | 8.56B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 4.62B | 3.29B | 2.57B | 1M | 2.64B | 1.72B | 5.12B | -3.57B | 2.94B | 2.21B |
Total non-current liabilities | 23.10B | 23.84B | 25.39B | 26.41B | 28.73B | 30.56B | 33.94B | 39.37B | 11.32B | 10.77B |
Total liabilities | 35.35B | 35.31B | 36.42B | 39.57B | 42.40B | 44.88B | 51.87B | 57.89B | 24.33B | 23.06B |
| Data source | Data source | Data source | Data source | Data source | Data source |